Development of expanding and differentiation-promoting system ex vivo for liver regeneration

肝再生体外扩增和分化促进系统的开发

基本信息

项目摘要

For the purpose of development of liver regeneration therapy, we attempted to develop the novel methods, by which human mesenchymal stem cells (MSCs) can be differentiated to mature hepatocytes. We used bone marrow-derived MSCs and cord blood-derived MSCs.1.Study by using bone marrow-derived MSCsUsing UE7T-13 cells, human bone marrow-derived MSCs which were retrovirally infected with human papilloma virus E7 and human telomerase reverse transcriptase (hTERT), 40 conditions of several cytokines, 5-azacytidine and type IV collagen coating were examined on hepatic differentiation of UE7T-13 cells. As a result, the optical condition for differentiation is type IV collagen-coating/aFGF/bFGF/HGF. By this condition, expression of hepatocyte-specific genes was highest. In addition, glycogen synthesis and urea synthesis was also greatly promoted by this treatment. Under this circumstance, WISP1 and WISP2 were down-regulated. Knockdown of WISP1 and WISP2 by siRNA also greatly enhanced hepatic differentiation of of MSCs.2.Study by using cord blood-derived MSCsUsing UCBTERT-21 cells, human cord blood-derived MSCs which were retrovirally infected with human telomerase reverse transcriptase (hTERT), 8 conditions of several cytokines, 5-azacytidine, HDAC inhibitor were examined on hepatic differentiation of UCBTERT-21 cells. As a result, the optical condition for differentiation is 5-azacytidine/HGF/aFGF/OSM. By this condition, expression of hepatocyte-specific genes was highest. In addition, glycogen syntheisis and urea syntheisis was also greatly promoted by this treatment. Under this circumstance, Wnt signal was down-regulated. Knockdown of fzd8, the receptor of Wnt, WISP1 also greatly enhanced hepatic differentiation of of MSCs.These results indicated new findings of hepatic differentiation of MSCs ; and contribute to the development of expanding and differentiation-promoting system ex vivo for liver regeneration.
为了开发肝再生疗法,我们试图开发新的方法,使人间充质干细胞(MSCs)能够分化为成熟的肝细胞。利用UE7T-13细胞、逆转录病毒感染的人骨髓间充质干细胞和人端粒酶逆转录酶(HTERT)、多种细胞因子、5-氮胞苷和IV型胶原涂层等40种条件对UE7T-13细胞的肝分化进行了研究。结果表明,诱导分化的最佳条件为IV型胶原涂层/aFGF/bFGF/HGF。在此条件下,肝细胞特异性基因的表达最高。此外,对糖原合成和尿素合成也有明显的促进作用。在这种情况下,WISP1和WISP2表达下调。2.以脐血MSCs为研究对象,观察了逆转录病毒感染人端粒酶逆转录酶(HTERT)、8种细胞因子、5-氮胞苷、HDAC抑制剂对脐血MSCs向UCBTERT-21细胞分化的影响。结果表明,分化的最佳条件为5-氮杂胞苷/HGF/aFGF/OSM。在此条件下,肝细胞特异性基因的表达最高。此外,对糖原合成和尿素合成也有明显的促进作用。在这种情况下,Wnt信号被下调。Wnt、WISP1受体FZD8基因的敲除也显著促进了MSCs的肝脏分化,这些结果提示了MSCs肝脏分化的新发现,并有助于建立体外扩增和分化促进系统以促进肝脏再生。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
消化器病学の進歩2005-モノグラフ- 消化器病学のニューフロンティア編
2005 年胃肠病学进展 - 专着 - 胃肠病学新前沿
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Fukutomi;T.;朝長毅
  • 通讯作者:
    朝長毅
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SHIOTA Goshi其他文献

SHIOTA Goshi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SHIOTA Goshi', 18)}}的其他基金

Enhancing effect of retinoids on anti-cancerous drugs by regulating intracellular molecules
类维生素A通过调节细胞内分子增强抗癌药物的作用
  • 批准号:
    25670368
  • 财政年份:
    2013
  • 资助金额:
    $ 9.15万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Large-scale screening system of low molecular compounds forrealization of regenerative medicine for liver diseases
低分子化合物大规模筛选系统,实现肝病再生医学
  • 批准号:
    23659650
  • 财政年份:
    2011
  • 资助金额:
    $ 9.15万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
レチノイン酸応答性の新規機能性RNAの同定による肝細胞癌の診療への応用
通过鉴定对视黄酸敏感的新型功能性RNA在肝细胞癌治疗中的应用
  • 批准号:
    20390209
  • 财政年份:
    2008
  • 资助金额:
    $ 9.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of method of transdifferentiation of human umbilical cord blood cells to hepatocyte
人脐带血细胞向肝细胞转分化方法的研制
  • 批准号:
    14570469
  • 财政年份:
    2002
  • 资助金额:
    $ 9.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Functional analysis of retinoic acid receptor in liver
肝脏视黄酸受体的功能分析
  • 批准号:
    10670473
  • 财政年份:
    1998
  • 资助金额:
    $ 9.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of anti-tumor effect of HGF in transgenic mice
HGF对转基因小鼠的抗肿瘤作用分析
  • 批准号:
    07807057
  • 财政年份:
    1995
  • 资助金额:
    $ 9.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Bone marrow mesenchymal stem cell transplantation prevents concurrent progression of chronic kidney disease and associated cerebrovascular disease
骨髓间充质干细胞移植可预防慢性肾病和相关脑血管疾病的并发进展
  • 批准号:
    23K08095
  • 财政年份:
    2023
  • 资助金额:
    $ 9.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Functional analysis of renal regeneration molecular mechanism by bone marrow mesenchymal stem cell transplantation for fibrosis after renal injury
骨髓间充质干细胞移植治疗肾损伤后纤维化肾再生分子机制的功能分析
  • 批准号:
    22K07939
  • 财政年份:
    2022
  • 资助金额:
    $ 9.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Exploring the Potential of Bone Marrow-derived Mesenchymal Stem Cell Extracts in Neural Degeneration and Regeneration
探索骨髓间充质干细胞提取物在神经变性和再生中的潜力
  • 批准号:
    565823-2021
  • 财政年份:
    2021
  • 资助金额:
    $ 9.15万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
Effects of bone marrow-derived mesenchymal stem cell transplantation in piglet Legg-Calve-Perthes disease models
骨髓间充质干细胞移植对仔猪Legg-Calve-Perthes病模型的影响
  • 批准号:
    20K18019
  • 财政年份:
    2020
  • 资助金额:
    $ 9.15万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the immunomodulatory mechanism of bone marrow mesenchymal stem cell therapy for the development of new neurological disease treatments
阐明骨髓间充质干细胞治疗的免疫调节机制,用于开发新的神经系统疾病治疗方法
  • 批准号:
    20K16554
  • 财政年份:
    2020
  • 资助金额:
    $ 9.15万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Analysis of cell kinetics by short-term stimulation of TNF-alfa on bone marrow-derived mesenchymal stem cell
TNF-α短期刺激骨髓间充质干细胞的细胞动力学分析
  • 批准号:
    19K24122
  • 财政年份:
    2019
  • 资助金额:
    $ 9.15万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Analysis of the biologic effects and the therapeutic mechanisms of bone marrow mesenchymal stem cell in the in vitro Alzheimer's disease model
骨髓间充质干细胞在阿尔茨海默病体外模型中的生物学效应及治疗机制分析
  • 批准号:
    18K15397
  • 财政年份:
    2018
  • 资助金额:
    $ 9.15万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Analysis of oxidative stress in the brain in Alzheimer's disease model mice and establishment of bone marrow mesenchymal stem cell therapy
阿尔茨海默病模型小鼠脑氧化应激分析及骨髓间充质干细胞疗法的建立
  • 批准号:
    17K16388
  • 财政年份:
    2017
  • 资助金额:
    $ 9.15万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Therapeutic effectiveness of human bone marrow mesenchymal stem cell transplantation in a rat model of crush Injury
人骨髓间充质干细胞移植对大鼠挤压伤模型的治疗效果
  • 批准号:
    16K20389
  • 财政年份:
    2016
  • 资助金额:
    $ 9.15万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Examine the effect of HMGB1 on bone marrow derived mesenchymal stem cell
检查HMGB1对骨髓间充质干细胞的影响
  • 批准号:
    16H06991
  • 财政年份:
    2016
  • 资助金额:
    $ 9.15万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了